Fosun Pharmaceutical 2196

Fosun Pharmaceutical 2196

Postby winston » Fri Oct 26, 2012 9:41 am

not vested

Investor suddenly withdraws orders for Fosun Pharmaceutical (02196.HK)'s globally offered shrs

Rumor has it that an investor, being a fund, suddenly withdreww orders worth US$100 million for Fosun Pharmaceutical (02196.HK)'s globally offered shares after the end of public offering, showing funds remain cautious to new shares.

Fosun Pharmaceutical made its way for listing, only by asking for funds from ABC and Haitong Securities, who were not its sponsors in the first place, and allocating capital to international tranche with certain funds obtained from public offering.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Fosun Pharmaceutical 2196

Postby winston » Fri Nov 16, 2012 3:08 pm

Social Security Fund takes 7.7% stake in FOSUN PHARMA (02196.HK) for over $300M

Social Security Fund took a 7.7% stake, which represented 25.87 million shares, in FOSUN PHARMA (02196.HK) at $11.8 apiece (the offer price) on average on October 30 (debut day), involving over $305 million, stock exchange data showed.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Fosun Pharmaceutical 2196

Postby winston » Thu Jan 24, 2013 2:58 pm

not vested

Value Partners raises holding in FOSUN PHARMA (02196.HK) to 7.94%

Value Partners, controlled by Cheah Cheng Hye, increased holding in FOSUN PHARMA (02196.HK) by a total of 9.9255 million shares during 16-18 January for $120 million.

The fund company's shareholding in FOSUN PHARMA rose from 4.98% to 7.94%.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Fosun Pharmaceutical 2196

Postby winston » Wed May 06, 2015 9:53 am

not vested

FOSUN PHARMA (02196.HK) 1Q net profit soars 29% in 1Q

FOSUN PHARMA (02196.HK) announced the first quarter report for the year ended 31 March 2015.

Based on General Accepted Accounting Principles of the People?s Republic of China (PRC GAAP), operating revenue inched up 5.4% from a year ago to RMB2.8 billion.

Net profit jumped 29% to RMB536 million, with EPS of 23 fen.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Fosun Pharmaceutical 2196

Postby winston » Wed May 06, 2015 9:56 am

not vested

April 17, 2015

<Post Resumption>FOSUN PHARMA (02196.HK)-H jumps 24% on proposed issue of A shares

FOSUN PHARMA (02196.HK) proposed a non-public issue of not more than 247 million A shares (with a lock-up period of 3 years) to subscribers including China Life at a price of RMB23.5 per share to raise up to RMB5.8 billion.

Net proceeds of RMB3.6 billion are intended to be use for debt repayment, with the remaining proceeds to be used for replenishment of working capital.

Meanwhile, Morgan Stanley expected the company to see a 70%-80% rise in the next 60 days.

FOSUN PHARMA-H opened up 33% this morning, hitting a fresh high at $35.15, and last traded at $32, up 24%, with volume surging to 7.47 million shares.

FOSUN PHARMA-A rose by its daily limit and set a new record high at $27.27.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Fosun Pharmaceutical 2196

Postby winston » Fri Oct 30, 2015 8:50 am

not vested

FOSUN PHARMA (02196.HK) 3Q Net Profit Up 5.5%

FOSUN PHARMA (02196.HK) 0.000 (0.000%) Short selling $1.21M; Ratio 12.078% announced the results for the first three quarters ended 30 September 2015.

Based on General Accepted Accounting Principles of the People’s Republic of China (PRC GAAP), operating revenue added 4.8% yearly to RMB9.073 billion.

Net profit grew 20% to RMB1.891 billion, with EPS of 82 fen.

For the third quarter, net profit rose 5.5% to RMB587 million, with EPS of 25 fen.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Fosun Pharmaceutical 2196

Postby winston » Mon Jul 04, 2016 9:15 am

not vested

Apr 29, 2016

<Results Ann>FOSUN PHARMA 1Q16 Net Profit RMB634M, Up 18.3%


FOSUN PHARMA (02196.HK) announced that the first quarter results of 2016, according to PRC GAAP, operating income was RMB3.226 billion, up 15.2% yearly; net profit was RMB634 million, up 18.3%, with an EPS 27 fen.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Fosun Pharmaceutical 2196

Postby winston » Wed Aug 03, 2016 10:09 am

not vested

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Maintain OUTPERFORM
Acquisition of Gland Pharma; SOTP valuation model updated EPS:

Fosun Pharma announced it is to acquire an 86.08% stake in Gland Pharma for ~US$1.26 bn, implying ~16x FY16 EV/EBITDA
and raise ~ US$800 mn debt to finance the deal, subject to approvals from shareholders and regulators.

Gland Pharma is a leading Indian injection drug exporter with reported FY15/16 revenue of ~Rmb1/1.3 bn, and net profit of
~Rmb209/314 mn. Its main products include anti-coagulant drug heparin sodium and anti-thrombosis drug sodium.

According to Fosun Pharma's management, this acquisition will enhance the company's R&D and manufacturing capabilities and
expand its distribution network in the global market.

We view the deal neutral because of:
(1) significant finance costs from the debt financing for the deal and potential amortisation expenses of intangible asset;
(2) uncertainties in the postacquisition business integration.

We update our SOTP valuation model which is not factored in this deal.

Our TP of HK$28.4 implies an upside of 51%.

Retain OUTPERFORM.

Source: CS
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Fosun Pharmaceutical 2196

Postby winston » Wed Aug 24, 2016 11:19 am

not vested

FOSUN PHARMA Surges 7% on 15% Rise in 1H16 Net Profit

FOSUN PHARMA (02196.HK) reclaimed 250MA ($21.18) this morning and last printed at $21.55, rebounding 7%, on rising volume to 2.55 million shares.

Its A shares also jumped 4% to RMB22.43.

The company delivered net profit of RMB1.5 billion in the first half of 2016, up 15% yearly.

EPS equaled 65 fen.

During the period, gross profit and operating revenue gained 24% and 17% yearly.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Fosun Pharmaceutical 2196

Postby winston » Wed Oct 19, 2016 7:46 am

not vested

FOSUN PHARMA Obtains GMP Certificate for Production Workshops of 3 Raw Material Drugs

FOSUN PHARMA (02196.HK) 0.000 (0.000%) Short selling $4.55M; Ratio 6.677% 's subsidiary obtained "Drug GMP Certificate" from China Food and Drug Administration (CFDA) for the production workshops of three raw material drugs Atorvastatin calcium, Glimepiride and Febuxostat for a term until 2021.

The group invested about RMB17 million.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Next

Return to D to K

Who is online

Users browsing this forum: No registered users and 5 guests

cron